RESEARCH TRIANGLE PARK – Biogen announced that it expects to create 150 new jobs over the next two years at its Global Business Center (GBS) in Research Triangle Park at an opening ceremony for GBS Tuesday morning.
Biogen, which develops and delivers innovative therapies for people who have serious neurological and neurodegenerative diseases, said its Global Business Center will support and connect its team members and services globally.
“GBS will support services across geographies, business units and functions, and in time, integrate processes and data from across the organization,” the company said in a statement.
Biogen has invested more than $125 million in its RTP campuses since 2016. The RTP, the company said, “Provides access to strong talent and allows us to build on our strong (23-year) footprint in the community.”
In the past year, the company has invested about $25 million to open its Oligonucleotide Synthesis Manufacturing facility in NC to produce a new modality in medicine known as anti-sense oligonucleotides (or ASOs).
Deep roots in NC
North Carolina Gov. Roy Cooper and Congressman David Price attended the opening Tuesday morning.
“Biogen is a global innovator in biotechnology with deep roots in North Carolina,” Cooper said. “The company’s decision to expand here proves that our state and its skilled workforce offer world-class employers everything they need to be successful.”
Congressman Price, (D-NC), said, “Biogen’s expansion of its Research Triangle Park facility reinforces North Carolina’s status as a global center of research and innovation. Investments like these will ensure our state continues to attract talented professionals from around the country and will contribute significantly to our state and national economy.
Scott Levin, president and CEO of the Research Triangle Foundation added, “Since 2013, more than $1 billion has been invested in RTP by companies like Biogen that see the value and opportunity of the Triangle Region. The Research Foundation and our counties continue to partner with Biogen to provide infrastructure support so it may continue its growth here.”
